Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone in childhood steroid-sensitive nephrotic syndrome
ISRCTN16645249Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of prednisolone in nephrosis (2 arms), sponsored by University of Birmingham. Primary endpoint: Time to first relapse. Started Feb 2011; status: completed.
02
Drugs
prednisolone
03
Conditions
nephrosis
Beyond the preview
Go deeper on ISRCTN16645249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16645249.